Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Effects of Label Noise on Deep Learning-Based Skin Cancer Classification
58
Zitationen
24
Autoren
2020
Jahr
Abstract
Recent studies have shown that deep learning is capable of classifying dermatoscopic images at least as well as dermatologists. However, many studies in skin cancer classification utilize non-biopsy-verified training images. This imperfect ground truth introduces a systematic error, but the effects on classifier performance are currently unknown. Here, we systematically examine the effects of label noise by training and evaluating convolutional neural networks (CNN) with 804 images of melanoma and nevi labeled either by dermatologists or by biopsy. The CNNs are evaluated on a test set of 384 images by means of 4-fold cross validation comparing the outputs with either the corresponding dermatological or the biopsy-verified diagnosis. With identical ground truths of training and test labels, high accuracies with 75.03% (95% CI: 74.39-75.66%) for dermatological and 73.80% (95% CI: 73.10-74.51%) for biopsy-verified labels can be achieved. However, if the CNN is trained and tested with different ground truths, accuracy drops significantly to 64.53% (95% CI: 63.12-65.94%, p<0.01) on a non-biopsy-verified and to 64.24% (95% CI: 62.66-65.83%, p<0.01) on a biopsy-verified test set. In conclusion, deep learning methods for skin cancer classification are highly sensitive to label noise and future work should use biopsy-verified training images to mitigate this problem.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.439 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.108 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.668 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.804 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.355 Zit.
Autoren
- Achim Hekler
- Jakob Nikolas Kather
- Eva Krieghoff‐Henning
- Jochen Utikal
- Friedegund Meier
- Frank Friedrich Gellrich
- Julius Upmeier zu Belzen
- Lars E. French
- Justin Gabriel Schlager
- Kamran Ghoreschi
- Tabea Wilhelm
- Heinz Kutzner
- Carola Berking
- Markus V. Heppt
- Sebastian Haferkamp
- Wiebke Sondermann
- Dirk Schadendorf
- Bastian Schilling
- Benjamin Izar
- Roman C. Maron
- Max Schmitt
- Stefan Fröhling
- Daniel B. Lipka
- Titus J. Brinker
Institutionen
- Heidelberg University(DE)
- National Center for Tumor Diseases(DE)
- German Cancer Research Center(DE)
- RWTH Aachen University(DE)
- Universitätsklinikum Aachen(DE)
- TU Dresden(DE)
- University Hospital Carl Gustav Carus(DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin(DE)
- Ludwig-Maximilians-Universität München(DE)
- Charité - Universitätsmedizin Berlin(DE)
- Dermatopathologie Friedrichshafen(DE)
- Universitätsklinikum Erlangen(DE)
- University Hospital Regensburg(DE)
- Essen University Hospital(DE)
- Universitätsklinikum Würzburg(DE)
- Dana-Farber Cancer Institute(US)
- Epigenomics (Germany)(DE)
- Otto-von-Guericke University Magdeburg(DE)